Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I’m in it to win it!!! :) :) :)
Don’t believe none of it ...it’s all a scam! lol
Go PharmaCyte!!!
Well I am in the camp that hopes the start at Eurofins will be announced before the end of December.
Nah! Still a bit too early for that. You’ll see .04 again soon enough.
Just MM’s and day traders manipulating for their shorting gains imo
Hopefully we will get some news soon enough.
If it was number one it still wouldn't matter imo. Looking forward, KW announcing the completion of CiaB and/or the cell banks and/or positive test results of both ARE THE ONLY MATERIAL ISSUES that will increase the buying interest of this company.
Old news is old news. Bring on new and positive developments.
You want awareness? ...just let these matters come to fruition.
Hoping for the best!!!
Prefer “gainful” news having significant value. Completing CiaB ...Completing the Cell Banks ...Testings completed with positive results. That’s all that matters actually.
Hoping to at least hear in December that Eurofins has begun.
A good positive PR is what we need. Those charts have been and continue to be totally useless.
Hats off to you Mazz!
Those charts have been and continue to be useless. A good positive PR is what we need.
What cells to Eurofins Pete?!! There are no cells going to Eurofins. The only thing we had going to them was the batch of the original medium.
The encapsulated cells (CiaB) being done by Austrianova will be completed and tested at Austrianova and will not be going to Eurofins.
TJ, at the time of that FB pic according to KW's timeline per the cc, you were more than likely seeing a pic(s) of the 1st attempt which failed, or even the 2nd attempt which had also failed because of the alternate culture medium.
Eurofins now has in house what I "HOPE" will work...a batch of the original medium.
At this point, all we can do is sit and wait for a PR.
KW is anticipating Eurofins will begin manufacturing the cell banks by the end of this month.
The original culture medium was ordered and delivered to Eurofins.
However, until Eurofins finishes cell bank work for another client, they cannot begin to manufacture ours.
Also, remember, Austrianova is still finishing up the encapsulated cells (CiaB).
CC 23:01
Until the cell banks are completed, and CiaB finished, and both tested, the IND cannot be submitted.
These are basically the final items needed to accompany the IND required by the FDA.
Cell banks are NOT completed.
You should listen to the cc again.
That's funny about the xmas gifts tulla. :)
As for the banks and CiaB, and the testing of both, we all know that will depend on both Austrianova and Eurofins efforts.
It could all be positive and wrapped up by end of Q1, but as you elude to...maybe not. That's a lot of work for such little time.
So, I agree, thinking way forward to Q2 would keep my anxiety level down. lol
And efood, I agree with you on the China potential utilizing the CiaB Technology (application) itself.
However, with regards to PC, whether it's China or anywhere else...the cells still must be identical (China FDA rules irrelevant). And the Melligen and Islet (alt) cells still have yet to work properly.
Getting the preferred cell banks and the Melligen Cells completed and tested @100% is key. If they are successful with just anyone of these two...KABOOM!!!...GLOBAL!!!
Let’s go Eurofins, bring it home!!!!!!
I found them on my iPad last week. I will search my history when I get in tonight and post it when I find it.
I believe I crossed them while researching Virusure.
Which other Bio?
Where are you Rudy????? :(
Efood, I’m merely speaking my mind, and in no way accusing or even suggesting that someone may have negatively interfered.
However, having a little sense of suspicion in the back of my mind of big pharma’s possible meanderings into CiaB’s work is absolutely justifiable, especially given the history of big Pharma and the way they do business.
We all know that their absurd greed for power and money is insane, and that they are defiant and ruthless. They will stop at nothing, and do everything in their power to keep the status quo of making their billions and billions.
I’m sure you agree because you’re to damn smart to argue otherwise.
Now, I appreciate the help you offer, and the dd you contribute to the board. However, I have to disagree if you’re trying to undermine my thought with your overly positive assertions of innocence, as if something like that would never happen.
Look, I’m in the same boat as you, hoping for success with CiaB therapies.
Am I still holding every single share? ...sure I am.
Do I still believe in the potential of CiaB’s therapy? ...sure I do.
Am I going to continue to be patient and wait for the results of the third attempt ...you bet.
But....do I believe it’s possible for big Pharma to “touch” the work of PharmaCyte?...absolutely.
Indeed. However, “substance” is all I am concerned about, or rather a successful third attempt. I would like to know why Virusure subcontracted to Arita. I don’t want to sound like a conspiracy therapist by no means, but what I found to be unfortunate and a bit odd was the timing of the audit. Just out of curiosity I’d like to learn everything about that audit order...everything.
I would also like to know what really happened with TD2.
Hoping Eurofins will pull it off.
Totally suprised that you would agree.
His strategy to move it lower just to give investors the opportunity to buy at a lower pps???
THAT IS LUDICROUS!!!!
Efood, it would be unfortunate, but I think Rudy may have jumped off. :( :( :(
Right. Thank you.
efood, could you please help me locate any credible info about PC being the new CRO? tia
Have yet to find any article/news mentioning that PharmaCyte is now working with Practical Clinical. Will continue to search...would appreciate any help.
Where is it said that Practical Clinical is the new CRO?
So Mick, I don’t understand your point. Everything you just posted is already known. ???
I wonder how much was paid to the Italian facility...and the compensation to Practical Clinical.
Perhaps we’ll find out in the next pr...if not there’s always the next filing to delve into.
...and go Brian!!!
Rudy?
So, how much longer are you going to keep us waiting Rudy?
Your insight is valued here and greatly appreciated.
I went back to review the presentation video where Susan Tessmann of TD2 never gave the slightest hint of an infrastructure problem.
I been trying to make contact with her to find out if Dr. von Hoff is still participating...no luck yet.
1234 was right, and his anger justified, when he was screaming about “5 months of waisted time”.
Oh well, chit happens, right?
We just keep moving forward.
For me, the Cell bank situation is nothing more than a setback.
The reasoning, or the sorry ass excuse as some here would preferred to say, is totally understandable.
I am 100% totally confident that Eurofins will complete the job, and the IND will be submitted.
Like most, I would like to of heard that there was more progression on the diabetes and ascites front.
But then again, I understand those areas still continue to need more time in there developments.
I hate that the Italian company screwed up our process with the auditing. However, I am now crystal clear on how we got to Eurofins.
Yes, that is entirely possible. Unfortunately, as usual...we’re left in the dark to piece it together again.
Perhaps the next shoe, “if” it falls (let’s hope not), will have something to do with Dr. von Hoff.
Maybe, that’s the smell.
But then again, I am totally totally totally speculating.
I don’t see any reasons why Dr. von Hoff would leave anyways.
No...but with Dr. von Hoff TD to was a shoe in.
Now, if von Hoff is to continue his work with PharmaCyte, there are hundreds of CRO’s between the United States and Europe alone that could be tapped.
Now must find out how Dr. Von Hoff continues to participate now after learning of TD2’s inability to carry out the trial.
Reworking